You are here: Industry Insights > biotech

News List

Pall Corp. Establishes Biotech CoE in Shanghai contractpharma
December 21, 2018
Pall Corp. has established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China. The CoE is a new facility for bioprocess engineering consultancy, technology demonstration, testing and training for China and broader Asia.
Amgen Golden Tickets provide startup companies with free lab space to further advance innovative science and technology worldpharmanews
December 19, 2018
Amgen and LabCentral today announced that Kernal Biologics and PanTher Therapeutics have each won the Amgen Golden Ticket at LabCentral.
Moderna shares slide after record $604m US listing pharmaphorum
December 11, 2018
RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut......
Defined Health becomes Cello Health BioConsulting pharmaphorum
December 03, 2018
Cello’s US health consulting business Defined Health has been rebranded as Cello Health BioConsulting, following its acquisition by the group last year.
Two Labs Acquires Pennside Partners Ltd. pharmafocusasia
November 28, 2018
Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd., an international provider of market insights....
How To Make Money In This Bear Market Dr. Tran
November 22, 2018
Since September 2018, it is not far from the truth that we are entering into an aggressive bear market that can potentially transition into a full-blown recession.
Lonza Acquires Octane Biotech contractpharma
October 30, 2018
Lonza Acquires Octane Biotech
US and Cuba form biotech joint venture to develop cancer drugs pharmaceutical-technology
September 29, 2018
US and Cuba have formed a biotech joint venture, called Innovative Immunotherapy Alliance, focused on the research and development of cancer drugs to prolong and improve survival of patients.
CDW Holding to sell part of loss-making biotech unit to controlling shareholder's son straitstimes
September 28, 2018
SINGAPORE - Precision parts maker CDW Holding is selling part of its interest in a loss-making biotechnology subsidiary to the son of its controlling shareholder, in a surrender of its majority stake.
Bayer taps veteran Sebastian Guth to lead American pharma as Carsten Brunn flees to biotech fiercepharma
September 28, 2018
Bayer’s pharma leader in the Americas is heading off to biotech, but the German drugmaker has a seasoned veteran ready to step up.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page